Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses.

Kalekar LA, Cohen JN, Prevel N, Sandoval PM, Mathur AN, Moreau JM, Lowe MM, Nosbaum A, Wolters PJ, Haemel A, Boin F, Rosenblum MD.

Sci Immunol. 2019 Sep 6;4(39). pii: eaaw2910. doi: 10.1126/sciimmunol.aaw2910.

PMID:
31492709
2.

Rare Protein-altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.

Ley B, Torgerson DG, Oldham JM, Adegunsoye A, Liu S, Li J, Elicker BM, Henry TS, Golden JA, Jones KD, Dressen A, Yaspan BL, Arron JR, Noth I, Hoffmann TJ, Wolters PJ.

Am J Respir Crit Care Med. 2019 Jul 3. doi: 10.1164/rccm.201902-0360OC. [Epub ahead of print]

PMID:
31268371
3.

Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.

Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley B.

Chest. 2019 Jun 7. pii: S0012-3692(19)31132-8. doi: 10.1016/j.chest.2019.05.014. [Epub ahead of print]

PMID:
31181198
4.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

5.

Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies.

Wolters PJ, Cottin V.

Eur Respir J. 2019 Mar 18;53(3). pii: 1900283. doi: 10.1183/13993003.00283-2019. Print 2019 Mar. No abstract available.

PMID:
30886027
6.

Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease.

Jhajj A, Gill HP, Hague CJ, Murphy D, Elicker B, Soon J, Sulaiman N, Castillo-Saldana D, Wilcox PG, Dunne J, Lee JS, Wolters PJ, Ley B, Jones KD, Morisset J, Ryerson CJ.

Eur Respir J. 2019 May 2;53(5). pii: 1802182. doi: 10.1183/13993003.02182-2018. Print 2019 May. No abstract available.

PMID:
30846470
7.

Association between greenhouse working exposure and bronchial asthma: A pilot, cross-sectional survey of 5,420 greenhouse farmers from northeast China.

Liu S, Wolters PJ, Zhang Y, Zhao M, Liu D, Wang L, Zhao G, Mao S, Wu L, Zhao H, Wang X.

J Occup Environ Hyg. 2019 Apr;16(4):286-293. doi: 10.1080/15459624.2019.1574973. Epub 2019 Mar 1.

PMID:
30822226
8.

Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.

Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, Brownell R, Liu S, Collard HR, Jones KD.

Histopathology. 2019 Jun;74(7):1088-1097. doi: 10.1111/his.13840. Epub 2019 Apr 25.

PMID:
30742318
9.

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.

Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, Butte AJ, Bhattacharya M.

Nat Immunol. 2019 Feb;20(2):163-172. doi: 10.1038/s41590-018-0276-y. Epub 2019 Jan 14.

10.

Telomere length and genetic variant associations with interstitial lung disease progression and survival.

Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G, Batra K, Torrealba J, Kozlitina J, Glazer C, Strek ME, Wolters PJ, Noth I, Garcia CK.

Eur Respir J. 2019 Apr 11;53(4). pii: 1801641. doi: 10.1183/13993003.01641-2018. Print 2019 Apr.

11.

Pirfenidone in the kaleidoscope: reflecting mechanisms through different angles.

Tzouvelekis A, Wolters PJ.

Eur Respir J. 2018 Nov 22;52(5). pii: 1802046. doi: 10.1183/13993003.02046-2018. Print 2018 Nov. No abstract available.

PMID:
30467176
12.

Response.

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR.

Chest. 2018 Sep;154(3):727-728. doi: 10.1016/j.chest.2018.05.042. No abstract available.

PMID:
30195362
13.

Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.

Zhang Y, Jones KD, Achtar-Zadeh N, Green G, Kukreja J, Xu B, Wolters PJ.

Histopathology. 2019 Jan;74(2):341-349. doi: 10.1111/his.13745. Epub 2018 Nov 11.

PMID:
30152895
14.

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR.

Lancet Respir Med. 2018 Sep;6(9):707-714. doi: 10.1016/S2213-2600(18)30301-1. Epub 2018 Aug 9.

PMID:
30100404
15.

Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.

Neighbors M, Cabanski CR, Ramalingam TR, Sheng XR, Tew GW, Gu C, Jia G, Peng K, Ray JM, Ley B, Wolters PJ, Collard HR, Arron JR.

Lancet Respir Med. 2018 Aug;6(8):615-626. doi: 10.1016/S2213-2600(18)30185-1. Epub 2018 Jun 29.

PMID:
30072107
16.

Two different R gene loci co-evolved with Avr2 of Phytophthora infestans and confer distinct resistance specificities in potato.

Aguilera-Galvez C, Champouret N, Rietman H, Lin X, Wouters D, Chu Z, Jones JDG, Vossen JH, Visser RGF, Wolters PJ, Vleeshouwers VGAA.

Stud Mycol. 2018 Mar;89:105-115. doi: 10.1016/j.simyco.2018.01.002. Epub 2018 Feb 7.

17.

Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.

Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M, Bhangale TR, Brauer MJ, Hunkapiller J, Reeder J, Mukhyala K, Cuenco K, Tom J, Cowgill A, Vogel J, Forrest WF, Collard HR, Wolters PJ, Kropski JA, Lancaster LH, Blackwell TS, Arron JR, Yaspan BL.

Lancet Respir Med. 2018 Aug;6(8):603-614. doi: 10.1016/S2213-2600(18)30135-8. Epub 2018 Jun 18.

18.

Gapless Genome Assembly of the Potato and Tomato Early Blight Pathogen Alternaria solani.

Wolters PJ, Faino L, van den Bosch TBM, Evenhuis B, Visser RGF, Seidl MF, Vleeshouwers VGAA.

Mol Plant Microbe Interact. 2018 Jul;31(7):692-694. doi: 10.1094/MPMI-12-17-0309-A. Epub 2018 May 18.

19.

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA.

Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9. Review.

20.

Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis.

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR.

Chest. 2018 Jul;154(1):119-125. doi: 10.1016/j.chest.2018.01.015. Epub 2018 Feb 7.

21.

Discovering Novel Alternaria solani Succinate Dehydrogenase Inhibitors by in Silico Modeling and Virtual Screening Strategies to Combat Early Blight.

Iftikhar S, Shahid AA, Halim SA, Wolters PJ, Vleeshouwers VGAA, Khan A, Al-Harrasi A, Ahmad S.

Front Chem. 2017 Nov 17;5:100. doi: 10.3389/fchem.2017.00100. eCollection 2017.

22.

Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.

Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B; HP Delphi Collaborators.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1036-1044. doi: 10.1164/rccm.201710-1986OC. Epub 2017 Nov 27.

23.

The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.

Ley B, Newton CA, Arnould I, Elicker BM, Henry TS, Vittinghoff E, Golden JA, Jones KD, Batra K, Torrealba J, Garcia CK, Wolters PJ.

Lancet Respir Med. 2017 Aug;5(8):639-647. doi: 10.1016/S2213-2600(17)30216-3. Epub 2017 Jun 22.

24.

Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.

Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE Jr, Collard HR, Lee JS.

Chest. 2017 Nov;152(5):999-1007. doi: 10.1016/j.chest.2017.06.009. Epub 2017 Jun 16.

25.

The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.

Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE Jr, Kim DS, Collard HR, Lee JS.

Respir Med. 2017 Jun;127:51-56. doi: 10.1016/j.rmed.2017.04.012. Epub 2017 Apr 22.

26.

A recurring theme in pulmonary fibrosis genetics.

Wolters PJ.

Eur Respir J. 2017 May 11;49(5). pii: 1700545. doi: 10.1183/13993003.00545-2017. Print 2017 May. No abstract available.

27.

Short lung transplant donor telomere length is associated with decreased CLAD-free survival.

Faust HE, Golden JA, Rajalingam R, Wang AS, Green G, Hays SR, Kukreja J, Singer JP, Wolters PJ, Greenland JR.

Thorax. 2017 Nov;72(11):1052-1054. doi: 10.1136/thoraxjnl-2016-209897. Epub 2017 Apr 26.

28.

Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease.

Van Dyken SJ, Liang HE, Naikawadi RP, Woodruff PG, Wolters PJ, Erle DJ, Locksley RM.

Cell. 2017 Apr 20;169(3):497-509.e13. doi: 10.1016/j.cell.2017.03.044.

29.

CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.

Jia G, Chandriani S, Abbas AR, DePianto DJ, N'Diaye EN, Yaylaoglu MB, Moore HM, Peng I, DeVoss J, Collard HR, Wolters PJ, Egen JG, Arron JR.

Thorax. 2017 Sep;72(9):780-787. doi: 10.1136/thoraxjnl-2015-207682. Epub 2017 Mar 1.

PMID:
28250200
30.

Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis.

Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, Koth LL.

Chest. 2017 Sep;152(3):502-509. doi: 10.1016/j.chest.2017.02.011. Epub 2017 Feb 20.

PMID:
28223152
31.

Effectoromics-Based Identification of Cell Surface Receptors in Potato.

Domazakis E, Lin X, Aguilera-Galvez C, Wouters D, Bijsterbosch G, Wolters PJ, Vleeshouwers VG.

Methods Mol Biol. 2017;1578:337-353. doi: 10.1007/978-1-4939-6859-6_29.

PMID:
28220439
32.

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE Jr, Wolters PJ, Collard HR, Ley B.

Thorax. 2017 May;72(5):424-429. doi: 10.1136/thoraxjnl-2016-209671. Epub 2017 Jan 12.

33.

Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.

Lofgren S, Hinchcliff M, Carns M, Wood T, Aren K, Arroyo E, Cheung P, Kuo A, Valenzuela A, Haemel A, Wolters PJ, Gordon J, Spiera R, Assassi S, Boin F, Chung L, Fiorentino D, Utz PJ, Whitfield ML, Khatri P.

JCI Insight. 2016 Dec 22;1(21):e89073. doi: 10.1172/jci.insight.89073.

34.

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.

Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B.

Chest. 2017 Mar;151(3):619-625. doi: 10.1016/j.chest.2016.10.029. Epub 2016 Nov 3.

35.

Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis.

Naikawadi RP, Disayabutr S, Mallavia B, Donne ML, Green G, La JL, Rock JR, Looney MR, Wolters PJ.

JCI Insight. 2016 Sep 8;1(14):e86704. doi: 10.1172/jci.insight.86704.

36.

Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.

Tatler AL, Goodwin AT, Gbolahan O, Saini G, Porte J, John AE, Clifford RL, Violette SM, Weinreb PH, Parfrey H, Wolters PJ, Gauldie J, Kolb M, Jenkins G.

PLoS One. 2016 Aug 5;11(8):e0158047. doi: 10.1371/journal.pone.0158047. eCollection 2016.

37.

miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.

Disayabutr S, Kim EK, Cha SI, Green G, Naikawadi RP, Jones KD, Golden JA, Schroeder A, Matthay MA, Kukreja J, Erle DJ, Collard HR, Wolters PJ.

PLoS One. 2016 Jun 30;11(6):e0158367. doi: 10.1371/journal.pone.0158367. eCollection 2016.

38.

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.

Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA.

BMC Genet. 2016 Jun 7;17(1):74. doi: 10.1186/s12863-016-0377-2.

39.

A diagnostic model for chronic hypersensitivity pneumonitis.

Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE Jr, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR.

Thorax. 2016 Oct;71(10):951-4. doi: 10.1136/thoraxjnl-2016-208286. Epub 2016 May 31.

40.

Brief Report: Whole-Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis.

Mak AC, Tang PL, Cleveland C, Smith MH, Kari Connolly M, Katsumoto TR, Wolters PJ, Kwok PY, Criswell LA.

Arthritis Rheumatol. 2016 Sep;68(9):2257-62. doi: 10.1002/art.39721.

41.

Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts.

Greenland JR, Wong CM, Ahuja R, Wang AS, Uchida C, Golden JA, Hays SR, Leard LE, Rajalingam R, Singer JP, Kukreja J, Wolters PJ, Caughey GH, Tang Q.

Transplantation. 2016 Oct;100(10):2090-8. doi: 10.1097/TP.0000000000001191.

42.

Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 Expression.

Tatler AL, Habgood A, Porte J, John AE, Stavrou A, Hodge E, Kerama-Likoko C, Violette SM, Weinreb PH, Knox AJ, Laurent G, Parfrey H, Wolters PJ, Wallace W, Alberti S, Nordheim A, Jenkins G.

J Biol Chem. 2016 Apr 29;291(18):9540-53. doi: 10.1074/jbc.M115.692368. Epub 2016 Feb 9.

43.

Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.

Withana NP, Ma X, McGuire HM, Verdoes M, van der Linden WA, Ofori LO, Zhang R, Li H, Sanman LE, Wei K, Yao S, Wu P, Li F, Huang H, Xu Z, Wolters PJ, Rosen GD, Collard HR, Zhu Z, Cheng Z, Bogyo M.

Sci Rep. 2016 Jan 22;6:19755. doi: 10.1038/srep19755.

44.

Interstitial lung diseases in the hospitalized patient.

Disayabutr S, Calfee CS, Collard HR, Wolters PJ.

BMC Med. 2015 Sep 25;13:245. doi: 10.1186/s12916-015-0487-0.

45.

Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria.

Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE Jr, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS.

Respir Med. 2015 Oct;109(10):1326-31. doi: 10.1016/j.rmed.2015.08.010. Epub 2015 Aug 15.

46.

Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.

Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, Dean MY, Hersh B, Wolters PJ, Tokman S, Arcasoy SM, Ramphal K, Greenland JR, Smith N, Heffernan P, Shah L, Shrestha P, Golden JA, Blumenthal NP, Huang D, Sonett J, Hays S, Oyster M, Katz PP, Robbins H, Brown M, Leard LE, Kukreja J, Bacchetta M, Bush E, D'Ovidio F, Rushefski M, Raza K, Christie JD, Lederer DJ.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1325-34. doi: 10.1164/rccm.201506-1150OC.

47.

The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.

Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE Jr, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR.

Respir Med. 2015 Aug;109(8):1058-62. doi: 10.1016/j.rmed.2015.06.012. Epub 2015 Jun 24.

48.

Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.

Kim SY, Diggans J, Pankratz D, Huang J, Pagan M, Sindy N, Tom E, Anderson J, Choi Y, Lynch DA, Steele MP, Flaherty KR, Brown KK, Farah H, Bukstein MJ, Pardo A, Selman M, Wolters PJ, Nathan SD, Colby TV, Myers JL, Katzenstein AL, Raghu G, Kennedy GC.

Lancet Respir Med. 2015 Jun;3(6):473-82. doi: 10.1016/S2213-2600(15)00140-X. Epub 2015 May 20.

PMID:
26003389
49.

Overexpression of inhibitor of DNA-binding 2 attenuates pulmonary fibrosis through regulation of c-Abl and Twist.

Yang J, Velikoff M, Agarwal M, Disayabutr S, Wolters PJ, Kim KK.

Am J Pathol. 2015 Apr;185(4):1001-11. doi: 10.1016/j.ajpath.2014.12.008. Epub 2015 Feb 3.

50.

Subacute onset of pulmonary langerhans cell histiocytosis with resolution after smoking cessation.

Wolters PJ, Elicker BM.

Am J Respir Crit Care Med. 2014 Dec 1;190(11):e64. doi: 10.1164/rccm.201405-0974IM. No abstract available.

PMID:
25436789

Supplemental Content

Loading ...
Support Center